Show simple item record

dc.contributor.authorCristea, Ileana
dc.contributor.authorAbarca, Hugo
dc.contributor.authorChristensen, Anne Elisabeth
dc.contributor.authorTrubnykova, Milana
dc.contributor.authorMehrasa, Roya
dc.contributor.authorPeters, Dorien J. M.
dc.contributor.authorHouge, Gunnar Douzgos
dc.contributor.authorHennekam, Raoul C. M.
dc.contributor.authorRødahl, Eyvind
dc.contributor.authorBruland, Ove
dc.contributor.authorBredrup, Cecilie
dc.date.accessioned2024-02-14T14:09:31Z
dc.date.available2024-02-14T14:09:31Z
dc.date.created2023-06-19T07:52:47Z
dc.date.issued2023
dc.identifier.issn0014-5793
dc.identifier.urihttps://hdl.handle.net/11250/3117620
dc.description.abstractOcular pterygium–digital keloid dysplasia (OPDKD) is a rare hereditary disease characterized by corneal ingrowth of vascularized conjunctival tissue early in life. Later, patients develop keloids on fingers and toes but are otherwise healthy. In a recently described family with OPDKD, we report the presence of a de novo c.770C > T, p.(Thr257Ile) variant in PELI2 in the affected individual. PELI2 encodes for the E3 ubiquitin ligase Pellino-2. In transgenic U87MG cells overexpressing Pellino-2 with the p.(Thr257Ile) amino acid substitution, constitutive activation of the NLRP3 inflammasome was observed. However, the Thr257Ile variant did not affect Pellino-2 intracellular localization, its binding to known interaction partners, nor its stability. Our findings indicate that constitutive autoactivation of the NLRP3 inflammasome contributes to the development of PELI2-associated OPDKD.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleA Pellino-2 variant is associated with constitutive NLRP3 inflammasome activation in a family with ocular pterygium–digital keloid dysplasiaen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 the authorsen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1002/1873-3468.14597
dc.identifier.cristin2155568
dc.source.journalFEBS Lettersen_US
dc.source.pagenumber1290-1299en_US
dc.identifier.citationFEBS Letters. 2023, 597 (9), 1290-1299.en_US
dc.source.volume597en_US
dc.source.issue9en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal